Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Phase Ⅱ, randomized, double-blind, comparator-controlled study to evaluate the efficacy,
safety and pharmacokinetics of single injection intercostal nerve block with HR18034 for
postoperative pain management compared with ropivacaine.